Washington University in St. Louis announced plans to acquire the St. Louis College of Pharmacy and take over its campus, folding the pharmacy program into WashU as its tenth school. The smaller university will phase out programs that don’t transfer. The deal aims to expand WashU’s clinical and pharmaceutical training capacity while stabilizing programs from a partner institution with declining enrollment and notable debt. If regulators approve the transaction, the acquisition will reshape local program arrays and preserve a historic pharmacy program under a larger research university umbrella. For regional higher education markets, the deal illustrates a growing trend: selective absorptions as a strategy to sustain professional programs and rationalize academic portfolios. University finance officers and academic leaders should watch the transition timelines, accreditation approvals for professional programs, and faculty and staff integration plans as models for other prospective acquisitions.